美国美迪生MDS Inc
MDS Inc.公司是一家全球性医疗保健和生物科技公司，已于美国与加拿大股票上市。 业务范围包括临床检验、放射性同位素生产、精密分析仪器之制造、协助制药及生技产业从事新药开发之研发服务，其年营收达20亿加币。 MDS Inc.全球员工有10000名以上，遍布在25个国家，在知识联系、软硬体结构各方面提供丰富的资源。

MDS Inc. is a global life sciences company that provides market-leading products and services that are used by its customers for the development of drugs, and the diagnosis and treatment of disease. The Company has more than 3,600 employees in 13 countries and net revenues of more than US$1.2 billion for the fiscal year ended October 31, 2008. MDS is a recognized global industry leader in the areas of analytical instruments, medical isotopes for molecular imaging, radiotherapeutics, and pharmaceutical contract research.

MDS's three core businesses – MDS Analytical Technologies, MDS Nordion and MDS Pharma Services – are at the forefront of innovation in their respective industry sectors.

Along with well-respected brands and strong product and service capabilities, MDS offers strong company leadership. The management team is focused on increasing value for all stakeholders, and on doing business by the Core Values of Commitment to Excellence, Trust, Respect, and Integrity to guide the way the Company does business.

What makes it all work is attracting and retaining the right people – employees who strive to deliver excellent results, and share our purpose of making a distinctive contribution to the health and well-being of people around the world.

is a global leader focused on the research, design, manufacture and marketing of state-of-the-art solutions for mass spectrometry, drug discovery and bioresearch. MDS Analytical Technologies products, which are sold to researchers or scientists around the world at pharmaceutical companies, academic and medical institutions and health and life sciences organizations, are designed to help accelerate the complex process of discovering and developing new drug compounds, understanding the causes of disease, and protecting the safety of food, water and the environment. The mass spectrometer product lines are sold globally through joint ventures with two of the world's leading analytical instrumentation and life sciences companies, Life Technologies (formed by the merger of Invitrogen and Applied Biosystems, Inc.), and PerkinElmer, Inc.
Learn more.

is a global leader in the provision of innovative technologies for use in medical imaging, targeted cancer treatments and the sterilization of medical devices. Based in Ottawa, its products and services benefit the lives of millions of people in more than 50 countries around the world. MDS Nordion products and services are used on a daily basis by pharmaceutical and biotechnology companies, medical-device manufacturers, hospitals, clinics, and research laboratories.

MDS Nordion supplies more than half of the world's medical isotopes to precisely diagnose, monitor and treat disease. It provides targeted cancer treatments for a variety of conditions, including liver and brain cancer, and non-Hodgkin's lymphoma. MDS Nordion technology is used to sterilize more than 40% of the world's single-use medical supplies, such as bandages, catheters and syringes, and it's been estimated that 80% of all surgical gloves in the world are sterilized using this technology.
Learn more.

is a global leader committed to delivering Quality On Time™ service. The contract research organization offers a range of resources to meet the drug discovery and development needs of the pharmaceutical and biotechnology industries. With facilities strategically located in key geographies throughout the world, MDS Pharma Services applies advanced scientific and technological expertise throughout the Early Stage drug discovery and development process (Discovery through Phase IIa).